VAMOROLONE - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2025-07-22
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:26:07
Label at a glance#
ProductVAMOROLONE
Active ingredientVAMOROLONE
Products#
Every source-derived product name is available through these pages.
- VAMOROLONE
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| VAMOROLONE | 8XP29XMB43 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AGAMREE | VAMOROLONE | Catalyst Pharmaceuticals, Inc. | fb376f09-cf9c-42b5-b4dd-02d5bcd73211 | 2026-01-22 | Warnings, Adverse reactions | VAMOROLONE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.